Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders
- Abigail Schweiger
- , Breno Diniz
- , Ginger Nicol
- , Julie Schweiger
- , Andes E. Dasklakis-Perez
- , Eric J. Lenze
- Division of Clinical Neuroscience and Behavioral Health Research
- Institute of Clinical and Translational Sciences (ICTS)
- Intellectual and Developmental Disabilities Research Center (IDDRC)
- mHealth Research Core
- School of Medicine
- Department of Psychiatry
- Bursky Center for Human Immunology and Immunotherapy
- Hope Center for Neurological Disorders
- COVID-19 Researchers
Research output: Contribution to journal › Article › peer-review
12
Link opens in a new tab
Scopus
citations